Senior insider sale
SVP, CRO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$5.13M
10.97K shares
What this filing means
TATSIS OURANIA plans to sell 10.97K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $5.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001959173-26-000975
Officer· SVP, CRO
Since Oct 2019
10.97K
Shares to sell
$5.13M
Approx. market value
1.50K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/17/2021
52.00Restricted Stock Vesting
Compensation
2/10/2021
1.45KTotal acquired1.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2021 | Restricted Stock Vesting Compensation | 52.00 | — |
2/10/2021 | Restricted Stock Vesting Compensation | 1.45K | — |
| Total | 1.50K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
466.00
Market value
$214.6K
2/11/2026
—Completed
Units to sell
4.50K
Market value
$2.14M
1/7/2026
—Completed
Units to sell
4.50K
Market value
$2.02M
12/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.50K
Market value
$750.0K
2/13/2026
Total
Units
10.97K
Value
$5.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 466.00 | $214.6K | — | Completed |
1/7/2026 | 4.50K | $2.14M | — | Completed |
12/3/2025 | 4.50K | $2.02M | — | Completed |
| Planned — Approximate Date | ||||
2/13/2026 | 1.50K | $750.0K | NASDAQ | Planned |
| Total | 10.97K | $5.13M | ||